CJC-1295 with DAC is a lyophilized, research-use-only peptide from the growth hormone releasing hormone (GHRH) analog family. The DAC — Drug Affinity Complex — is a modification that allows the peptide to bind reversibly to serum albumin in research models, which extends its presence well beyond what a standard GHRH fragment shows. That makes it a useful reference compound for researchers studying longer-duration receptor activity, as opposed to the short, sharp activity window seen with CJC-1295 No DAC. Helix Bio supplies this peptide strictly for laboratory and research applications — it is not intended, labeled, or sold for human use.
HPLC certified
Independent analysis
Highest standard
Full traceability
CJC-1295 with DAC is a synthetic GHRH analog built on the same core sequence as CJC-1295 No DAC, with the addition of the Drug Affinity Complex — a chemical modification that lets the molecule bind to albumin in circulation. In research models, that binding is what gives the DAC version its extended presence compared to the No DAC variant. Researchers studying prolonged GHRH receptor activation, or comparing short- versus long-acting analog behavior, often use this compound as the long-acting reference point.
The product is a lyophilized (freeze-dried) powder consisting of the CJC-1295 with DAC peptide. As with other lyophilized peptides, this form is used to protect the compound's integrity during storage and shipping, since peptides in solution break down much faster than they do as a dry powder.
This product is manufactured and sold exclusively for in vitro laboratory research, analytical testing, and other non-clinical scientific applications. It is not a drug, dietary supplement, or cosmetic, and it is not approved by the FDA for diagnostic, therapeutic, or any other human or veterinary use.
If your protocol calls for a longer observation window than a standard GHRH fragment provides, CJC-1295 with DAC is the more relevant reference compound. Its albumin-binding behavior is well documented in the research literature, and it's frequently used as the long-acting comparison point against CJC-1295 No DAC or shorter-acting secretagogues like Ipamorelin. Helix Bio sources and packages this peptide specifically for the research community, with documentation practices designed to support reproducible laboratory work rather than retail or personal use.
This product is not intended for individual consumers, and Helix Bio does not sell it for personal, medical, or performance use.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
